Markets
Visualizing the Future of the Pharma Market
Visualizing the Future of the Pharma Market
Around the world, people are living longer.
By 2050, there will be two billion people that are 60 years or older globally. Meanwhile, the amount of seniors (65+ years old) in the U.S. will double to 100 million by 2060.
To meet the needs of this aging population, we will continue to need larger quantities and more varieties of prescription drug treatments – an industry that is expected to skyrocket to $1.2 trillion in size by 2024.
Drug Sales, by Segment
Today’s infographic comes to us from Raconteur, and it highlights the most anticipated drug treatments and therapy areas for the pharmaceutical industry.
It starts by breaking down the massive pharma market into therapy segments, showing a forecast for the size and growth for each category.
Here is the data for the top 15 segments, sorted by projected worldwide prescription drug sales in 2024:
Rank | Therapy Area | 2017 sales | 2024 sales | CAGR |
---|---|---|---|---|
#1 | Oncology | $104B | $233B | +12.2% |
#2 | Anti-diabetics | $46.1B | $59.5B | +3.3% |
#3 | Anti-rheumatics | $55.7B | $56.7B | +0.2% |
#4 | Vaccines | $27.7B | $44.6B | +7.1% |
#5 | Anti-virals | $42.4B | $39.9B | -0.9% |
#6 | Immunosuppressants | $13.7B | $38.1B | +15.7% |
#7 | Bronchodilators | $27.2B | $32.3B | +2.5% |
#8 | Dermatologicals | $12.9B | $30.3B | +13% |
#9 | Sensory Organs | $21.6B | $26.9B | +3.2% |
#10 | Anti-hypertensives | $23B | $24.4B | +0.8% |
#11 | Anti-coagulants | $16.8B | $22.9B | +4.6% |
#12 | MS Therapies | $22.7B | $21.5B | -0.8% |
#13 | Anti-fibrinolytics | $12.7B | $20.4B | +7.1% |
#14 | Anti-hyperlipidaemics | $11.3B | $16.4B | +5.5% |
#15 | Anti-anaemics | $7.6B | $15.7B | +11% |
Other | $379B | $567B | +5.9% | |
Total | $825B | $1249B | +6.1% |
This data, which comes from a recent report from EvaluatePharma, helps showcase a few key insights.
Firstly, the oncology therapy area – which makes drugs that are used to treat various forms of cancer – is by far the largest in the pharma world with $107 billion in sales in 2017. It’s also projected to maintain its dominance going forward, growing at an impressive 12.2% CAGR to $233 billion by 2024.
Next, while sales in cancer-related drugs will be the most in absolute terms, the fastest growing treatment area is actually in immunosuppressants – a segment of drugs that make a body less likely to reject a transplanted organ, such as a liver, heart, or kidney. It’s projected that this segment will grow at 15.7% per year, eventually becoming the sixth largest pharma segment at $38.1 billion in 2024.
Lastly, while sales in the pharma market will be averaging 6.1% in annual growth as a whole, there are two major segments that will see negative annual growth going forward: Anti-virals (-0.9%) and MS Therapies (-0.8%).
The Battle Against Cancer
Currently, there are more drugs used for treating cancer than for any other type of disease or condition.
Rank | Disease or Condition | Number of active drugs |
---|---|---|
#1 | Breast cancer | 727 |
#2 | Lung cancer | 544 |
#3 | Colorectal cancer | 503 |
#4 | Ovarian cancer | 434 |
#5 | Pancreatic cancer | 430 |
#6 | Type-2 diabetes | 407 |
#7 | Prostate cancer | 381 |
- | Alzheimer's disease | 381 |
Unfortunately, even though many cancer drugs are available on the market already, the debilitating disease is still a leading cause of death. Existing drugs are used in treatments of chemotherapy or hormone therapy, but it’s clear that there is still plenty of room for progress to be made against the disease.
For these reasons – combined with the estimate that nearly 40% of Americans will be diagnosed with some form of cancer during their lifetimes – it’s no surprise to see that companies have yet even more cancer drugs in the pipeline:
Rank | Therapy area | Number of drugs in pipeline |
---|---|---|
#1 | Anti-cancer | 5,212 |
#2 | Biotechnology | 4,751 |
#3 | Neurological | 2,604 |
#4 | Anti-infective | 2,238 |
#5 | Alimentary/metabolic | 2,237 |
#6 | Reformulations | 2,073 |
#7 | Musculoskeletal | 1,597 |
#8 | Dermatological | 929 |
As more drugs get approved from the above pipeline, it is projected that $1 of every $5 spent on prescription drugs in 2024 will be going towards cancer-related treatments.
Real Estate
Mapped: The Growth in House Prices by Country
Global house prices were resilient in 2022, rising 6%. We compare nominal and real price growth by country as interest rates surged.

Mapped: The Growth in House Prices by Country
This was originally posted on Advisor Channel. Sign up to the free mailing list to get beautiful visualizations on financial markets that help advisors and their clients.
Global housing prices rose an average of 6% annually, between Q4 2021 and Q4 2022.
In real terms that take inflation into account, prices actually fell 2% for the first decline in 12 years. Despite a surge in interest rates and mortgage costs, housing markets were noticeably stable. Real prices remain 7% above pre-pandemic levels.
In this graphic, we show the change in residential property prices with data from the Bank for International Settlements (BIS).
The Growth in House Prices, Ranked
The following dataset from the BIS covers nominal and real house price growth across 58 countries and regions as of the fourth quarter of 2022:
Price Growth Rank | Country / Region | Nominal Year-over-Year Change (%) | Real Year-over-Year Change (%) |
---|---|---|---|
1 | ๐น๐ท Tรผrkiye | 167.9 | 51.0 |
2 | ๐ท๐ธ Serbia | 23.1 | 7.0 |
3 | ๐ท๐บ Russia | 23.1 | 9.7 |
4 | ๐ฒ๐ฐ North Macedonia | 20.6 | 1.0 |
5 | ๐ฎ๐ธ Iceland | 20.3 | 9.9 |
6 | ๐ญ๐ท Croatia | 17.3 | 3.6 |
7 | ๐ช๐ช Estonia | 16.9 | -3.0 |
8 | ๐ฎ๐ฑ Israel | 16.8 | 11.0 |
9 | ๐ญ๐บ Hungary | 16.5 | -5.1 |
10 | ๐ฑ๐น Lithuania | 16.0 | -5.5 |
11 | ๐ธ๐ฎ Slovenia | 15.4 | 4.2 |
12 | ๐ง๐ฌ Bulgaria | 13.4 | -3.2 |
13 | ๐ฌ๐ท Greece | 12.2 | 3.7 |
14 | ๐ต๐น Portugal | 11.3 | 1.3 |
15 | ๐ฌ๐ง United Kingdom | 10.0 | -0.7 |
16 | ๐ธ๐ฐ Slovak Republic | 9.7 | -4.8 |
17 | ๐ฆ๐ช United Arab Emirates | 9.6 | 2.9 |
18 | ๐ต๐ฑ Poland | 9.3 | -6.9 |
19 | ๐ฑ๐ป Latvia | 9.1 | -10.2 |
20 | ๐ธ๐ฌ Singapore | 8.6 | 1.9 |
21 | ๐ฎ๐ช Ireland | 8.6 | -0.2 |
22 | ๐จ๐ฑ Chile | 8.2 | -3.0 |
23 | ๐ฏ๐ต Japan | 7.9 | 3.9 |
24 | ๐ฒ๐ฝ Mexico | 7.9 | -0.1 |
25 | ๐ต๐ญ Philippines | 7.7 | -0.2 |
26 | ๐บ๐ธ United States | 7.1 | 0.0 |
27 | ๐จ๐ฟ Czechia | 6.9 | -7.6 |
28 | ๐ท๐ด Romania | 6.7 | -7.5 |
29 | ๐ฒ๐น Malta | 6.3 | -0.7 |
30 | ๐จ๐พ Cyprus | 6.3 | -2.9 |
31 | ๐จ๐ด Colombia | 6.3 | -5.6 |
32 | ๐ฑ๐บ Luxembourg | 5.6 | -0.5 |
33 | ๐ช๐ธ Spain | 5.5 | -1.1 |
34 | ๐จ๐ญ Switzerland | 5.4 | 2.4 |
35 | ๐ณ๐ฑ Netherlands | 5.4 | -5.3 |
36 | ๐ฆ๐น Austria | 5.2 | -4.8 |
37 | ๐ซ๐ท France | 4.8 | -1.2 |
38 | ๐ง๐ช Belgium | 4.7 | -5.7 |
39 | ๐น๐ญ Thailand | 4.7 | -1.1 |
40 | ๐ฟ๐ฆ South Africa | 3.1 | -4.0 |
41 | ๐ฎ๐ณ India | 2.8 | -3.1 |
42 | ๐ฎ๐น Italy | 2.8 | -8.0 |
43 | ๐ณ๐ด Norway | 2.6 | -3.8 |
44 | ๐ฎ๐ฉ Indonesia | 2.0 | -3.4 |
45 | ๐ต๐ช Peru | 1.5 | -6.3 |
46 | ๐ฒ๐พ Malaysia | 1.2 | -2.6 |
47 | ๐ฐ๐ท South Korea | -0.1 | -5.0 |
48 | ๐ฒ๐ฆ Morocco | -0.1 | -7.7 |
49 | ๐ง๐ท Brazil | -0.1 | -5.8 |
50 | ๐ซ๐ฎ Finland | -2.3 | -10.2 |
51 | ๐ฉ๐ฐ Denmark | -2.4 | -10.6 |
52 | ๐ฆ๐บ Australia | -3.2 | -10.2 |
53 | ๐ฉ๐ช Germany | -3.6 | -12.1 |
54 | ๐ธ๐ช Sweden | -3.7 | -13.7 |
55 | ๐จ๐ณ China | -3.7 | -5.4 |
56 | ๐จ๐ฆ Canada | -3.8 | -9.8 |
57 | ๐ณ๐ฟ New Zealand | -10.4 | -16.5 |
58 | ๐ญ๐ฐ Hong Kong SAR | -13.5 | -15.1 |
Tรผrkiyeโs property prices jumped the highest globally, at nearly 168% amid soaring inflation.
Real estate demand has increased alongside declining interest rates. The government drastically cut interest rates from 19% in late 2021 to 8.5% to support a weakening economy.
Many European countries saw some of the highest price growth in nominal terms. A strong labor market and low interest rates pushed up prices, even as mortgage rates broadly doubled across the continent. For real price growth, most countries were in negative territoryโnotably Sweden, Germany, and Denmark.
Nominal U.S. housing prices grew just over 7%, while real price growth halted to 0%. Prices have remained elevated given the stubbornly low supply of inventory. In fact, residential prices remain 45% above pre-pandemic levels.
How Do Interest Rates Impact Property Markets?
Global house prices boomed during the pandemic as central banks cut interest rates to prop up economies.
Now, rates have returned to levels last seen before the Global Financial Crisis. On average, rates have increased four percentage points in many major economies. Roughly three-quarters of the countries in the BIS dataset witnessed negative year-over-year real house price growth as of the fourth quarter of 2022.
Interest rates have a large impact on property prices. Cross-country evidence shows that for every one percentage point increase in real interest rates, the growth rate of housing prices tends to fall by about two percentage points.
When Will Housing Prices Fall?
The rise in U.S. interest rates has been counteracted by homeowners being reluctant to sell so they can keep their low mortgage rates. As a result, it is keeping inventory low and prices high. Homeowners canโt sell and keep their low mortgage rates unless they meet strict conditions on a new property.
Additionally, several other factors impact price dynamics. Construction costs, income growth, labor shortages, and population growth all play a role.
With a strong labor market continuing through 2023, stable incomes may help stave off prices from falling. On the other hand, buyers with floating-rate mortgages face steeper costs and may be unable to afford new rates. This could increase housing supply in the market, potentially leading to lower prices.
-
Markets3 weeks ago
Charting the Rise of America’s Debt Ceiling
-
Technology4 days ago
Ranked: Americaโs Largest Semiconductor Companies
-
China3 weeks ago
Ranked: The Cities with the Most Skyscrapers in 2023
-
Markets4 days ago
The Fastest Rising Asset Classes in 2023
-
Urbanization3 weeks ago
Ranked: The World’s Biggest Steel Producers, by Country
-
Markets3 days ago
Mapped: The State of Economic Freedom in 2023
-
Announcement2 weeks ago
Join Us For Data Creator Con 2023
-
Datastream2 days ago
The 10 Longest Range EVs for 2023